Artificial intelligence (AI) holds great potential to impact the diagnosis and risk stratification of breast cancer. Current breast cancer risk models are limited in their design and accuracy. In this webinar, Dr. Constance Lehman, Professor of Radiology at Harvard Medical School and head of Breast Imaging at Massachusetts General Hospital will explore progress in applying AI to improve prediction of future risk of breast cancer based on mammography alone, including validation trials in multi-ethnic populations. These advances will be discussed in the context of the broader goal to deliver more precise, more personalized breast cancer detection, diagnosis and treatment.